Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

BBH vs SHPAX overlap: 22% of top holdings shared

Bottom line

How much do BBH and SHPAX overlap?

22% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 48.7% of BBH's assets and 25.3% of SHPAX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

BBHSHPAX
Weight overlap (top 25)22%
Shared holdings6
Weight in shared holdings48.7%25.3%
Total positions2529
Expense ratio0.35%3%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings BBH and SHPAX have in common

Holding% of BBH% of SHPAXOverlap
Amgen Inc15.25%5.04%5.04%
Gilead Sciences Inc12.79%3.94%3.94%
Vertex Pharmaceuticals Inc9.10%3.36%3.36%
Regeneron Pharmaceuticals Inc6.21%3.93%3.93%
United Therapeutics Corp2.83%6.17%2.83%
Incyte Corp2.49%2.89%2.49%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in BBH

  1. Revolution Medicines Inc — 5.27%
  2. Argenx SE — 4.97%
  3. Natera Inc — 4.92%
  4. IQVIA Holdings Inc — 4.31%
  5. Alnylam Pharmaceuticals Inc — 3.83%
  6. Biogen Inc — 3.63%
  7. Moderna Inc — 3.36%
  8. Illumina Inc — 3.17%
  9. BeOne Medicines Ltd — 2.81%
  10. Insmed Inc — 2.67%
  11. Neurocrine Biosciences Inc — 2.08%
  12. BioNTech SE — 1.94%
  13. Icon Plc — 1.90%
  14. Bio-Techne Corp — 1.54%
  15. Charles River Laboratories International Inc — 1.50%

Only in SHPAX

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. Mckesson Corp — 4.90%
  4. Lantheus Holdings Inc — 4.64%
  5. Exelixis Inc — 4.55%
  6. Novartis Ag — 4.50%
  7. Cencora Inc — 4.33%
  8. Johnson & Johnson — 3.91%
  9. National Healthcare Corp — 3.72%
  10. Merck & Company Inc — 3.63%
  11. Cigna Group (the) — 3.63%
  12. Medpace Holdings Inc — 3.37%
  13. Intuitive Surgical Inc — 3.14%
  14. Bristol-myers Squibb Company — 3.07%
  15. Stryker Corp — 2.40%

Asset mix

Asset typeBBHSHPAX
Stocks100.0%99.0%
Cash & short-term funds0.1%1.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryBBHSHPAX
US87.3%86.1%
IE1.9%8.4%
NL6.0%—
CH2.8%4.5%
DE1.9%—
DK—1.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do BBH and SHPAX overlap?
About 22% by weight. 6 securities appear in both funds' top 25 holdings; they make up 48.7% of BBH's assets and 25.3% of SHPAX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do BBH and SHPAX have in common?
The largest shared holdings are Amgen Inc, Gilead Sciences Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, United Therapeutics Corp.
Should I own both BBH and SHPAX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, BBH or SHPAX?
SHPAX is broader, with 29 positions versus 25 for BBH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.